Nilotinib appears safe and affects biomarkers in Alzheimer's disease clinical trial
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a ...
May 29, 2020
0
22